These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30682452)

  • 1. A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma.
    Fricker M; Gibson PG; Powell H; Simpson JL; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Marks GB; Baraket M; Baines KJ
    J Allergy Clin Immunol; 2019 Jul; 144(1):51-60.e11. PubMed ID: 30682452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.
    Baines KJ; Simpson JL; Wood LG; Scott RJ; Fibbens NL; Powell H; Cowan DC; Taylor DR; Cowan JO; Gibson PG
    J Allergy Clin Immunol; 2014 Apr; 133(4):997-1007. PubMed ID: 24582314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD.
    Baines KJ; Negewo NA; Gibson PG; Fu JJ; Simpson JL; Wark PAB; Fricker M; McDonald VM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1577-1590. PubMed ID: 32669843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six gene and TH2 signature expression in endobronchial biopsies of participants with asthma.
    Sánchez-Ovando S; Baines KJ; Barker D; Wark PA; Simpson JL
    Immun Inflamm Dis; 2020 Mar; 8(1):40-49. PubMed ID: 31903716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sputum gene expression signature predicts oral corticosteroid response in asthma.
    Berthon BS; Gibson PG; Wood LG; MacDonald-Wicks LK; Baines KJ
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28663317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sputum 6-gene signature predicts airway inflammation endotypes and exacerbation frequency in chronic obstructive pulmonary disease.
    Southworth T; Jevnikar Z; McCrae C; Singh D
    Biomark Med; 2022 Mar; 16(4):277-289. PubMed ID: 35176870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
    Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
    J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full blood count parameters for the detection of asthma inflammatory phenotypes.
    Zhang XY; Simpson JL; Powell H; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Lin JT; Gibson PG
    Clin Exp Allergy; 2014 Sep; 44(9):1137-45. PubMed ID: 24849076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.
    Hastie AT; Moore WC; Li H; Rector BM; Ortega VE; Pascual RM; Peters SP; Meyers DA; Bleecker ER;
    J Allergy Clin Immunol; 2013 Jul; 132(1):72-80. PubMed ID: 23706399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
    Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
    Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment.
    Niessen NM; Gibson PG; Baines KJ; Barker D; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Marks GB; Baraket M; Simpson JL; Fricker M
    Allergy; 2021 Jul; 76(7):2090-2101. PubMed ID: 33569770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED.
    Kuo CS; Pavlidis S; Loza M; Baribaud F; Rowe A; Pandis I; Hoda U; Rossios C; Sousa A; Wilson SJ; Howarth P; Dahlen B; Dahlen SE; Chanez P; Shaw D; Krug N; Sandstrӧm T; De Meulder B; Lefaudeux D; Fowler S; Fleming L; Corfield J; Auffray C; Sterk PJ; Djukanovic R; Guo Y; Adcock IM; Chung KF;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):443-455. PubMed ID: 27580351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
    van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
    Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma.
    Soma T; Iemura H; Naito E; Miyauchi S; Uchida Y; Nakagome K; Nagata M
    Allergol Int; 2018 Sep; 67S():S3-S11. PubMed ID: 29754974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
    Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
    Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy.
    Shukla SD; Taylor SL; Gibson PG; Barker D; Upham JW; Yang IA; Reynolds PN; Hodge S; James AL; Rogers GB; Simpson JL
    Thorax; 2021 Jul; 76(7):733-736. PubMed ID: 33414242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of inflammatory phenotypes among patients with asthma: relationships of blood count parameters with sputum cellular phenotypes.
    Shi B; Li W; Hao Y; Dong H; Cao W; Guo J; Gao P
    Allergy Asthma Clin Immunol; 2021 May; 17(1):47. PubMed ID: 33975625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
    Katz LE; Gleich GJ; Hartley BF; Yancey SW; Ortega HG
    Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ; Fu JJ; McDonald VM; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of sputum cell counts during spontaneous moderate exacerbations of asthma in comparison to the stable phase.
    Di Franco A; Bartoli ML; Carnevali S; Cianchetti S; Bacci E; Dente FL; Giannini D; Taccola M; Vagaggini B; Paggiaro PL
    J Asthma; 2003 Apr; 40(2):155-62. PubMed ID: 12765317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.